Lung cancer trials in Norway

In Norway 23 Also abroad 2733

23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Where
Brumunddal, Drammen, Loerenskog, Oslo
Age
18 years and over
People
780 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06312137 · EU 2023-508012-35-00
Phase 3Taking people
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Where
Bergen, Oslo, Trondheim
Age
18 years and over
People
670 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07472517 · EU 2025-520565-51-00
Phase 3Taking people
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Where
Bergen, Drammen, Gjoevik, Loerenskog, Oslo, Stavanger, Trondheim
Age
18 years and over
People
1,264 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06119581 · EU 2023-503412-33-00
Phase 3Taking people
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Where
Arendal, Bergen, Drammen, Gjøvik, Oslo
Age
18 years and over
People
700 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06890598 · EU 2024-512302-25-00
Phase 2Taking people
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Where
Bergen, Oslo
Age
18 years and over
People
254 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07492680
Phase 2/3Taking people
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Where
Drammen
Age
18 years and over
People
626 worldwide
Run by
Mirati Therapeutics Inc.
See details and how to joinNCT04613596 · EU 2023-508922-83-00
No phaseNot yet taking people in Norway
New Smoking Cessation Intervention in Primary Care - a Randomized Controlled Trial
Where
Levanger
Age
18 years and over
People
620
Run by
Helse Nord-Trøndelag HF
See details and how to joinNCT07900724
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Lørenskog, Oslo
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 2/3Taking people
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Where
Oslo
Age
18 years and over
People
590 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07063745 · EU 2025-521511-40-00
Phase 3Taking people
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Where
Drammen, Graalum
Age
18 years and over
People
750 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00
Phase 3Taking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Bergen, Drammen, Oslo
Age
18 years and over
People
695 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06801834
No phaseTaking people
Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial
Where
Oslo
Age
18 years and over
People
118 worldwide
Run by
University of Edinburgh
See details and how to joinNCT07255066
Phase 3Taking people
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
Where
Drammen, Gjoevik, Oslo
Age
18 years and over
People
263 worldwide
Run by
Zai Lab (US) LLC
See details and how to join2025-522818-23-00 · EU 2025-522818-23-00
Phase 2/3Not yet taking people in Norway
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy
Where
Bergen, Drammen, Oslo
Age
18 years and over
People
173 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2025-521908-22-00 · EU 2025-521908-22-00
Phase 2/3Taking people
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Where
Bergen, Drammen, Oslo
Age
18 years and over
People
500 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07100080
No phaseTaking people
Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
Where
Levanger, Trondheim
Age
18 years and over
People
50
Run by
Norwegian University of Science and Technology
See details and how to joinNCT05739331
Phase 2Not yet taking people in Norway
A phase II randomised trial investigating the benefit of adjuvant immunotherapy after neoadjuvant chemoimmunotherapy for resectable NSCLC (ADIL)
Where
Bergen, Lorenskog, Oslo, Tromsoe, Trondheim
Age
18 years and over
People
300 worldwide
Run by
Oslo Universitetssykehus HF
See details and how to join2025-524439-38-00 · EU 2025-524439-38-00
No phaseTaking people
Lung cAncer Robotic Comparative Study
Where
Loerenskog
Age
18 years and over
People
600 worldwide
Run by
Intuitive Surgical
See details and how to joinNCT06038227
Phase 3Taking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Bergen, Drammen, Oslo
Age
18 years and over
People
355 worldwide
Run by
Gilead Sciences Inc.
See details and how to join2024-515884-69-00 · EU 2024-515884-69-00
Phase 3Not yet taking people in Norway
Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?
Where
Aalesund, Bergen, Bodo, Drammen, Haugesund, Kristiansand S, Levanger, Lorenskog, Oslo, Stavanger, Tromsoe, Trondheim
Age
18 years and over
People
426 worldwide
Run by
Norges Teknisk-Naturvitenskapelige Universitet NTNU
See details and how to join2026-525513-31-00 · EU 2026-525513-31-00
No phaseTaking people
Akershus Cardiac Examination (ACE) 5 Study
Where
Lørenskog
Age
60 years to 79 years
People
1,000
Run by
University Hospital, Akershus
See details and how to joinNCT07301489
Phase 1/2Taking people
COMBINATORY IMMUNOTHERAPY-2 (COM-IT-2) A phase 2 randomised open two-arm study to assess the tolerability and efficacy of immunotherapy combined with extensive radiotherapyfor the treatment of stage IV non-small cell lung cancer
Where
Gjoevik, Oslo, Trondheim
Age
18 years and over
People
55
Run by
Oslo University Hospital HF
See details and how to join2023-510089-28-00 · EU 2023-510089-28-00
Phase 2Taking people
Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Where
Brumunddal, Drammen, Foerde, Levanger, Loerenskog, Oslo, Stavanger, Tromsoe, Trondheim
Age
18 years and over
People
138
Run by
Vestre Viken Hospital Trust
See details and how to joinNCT05344209 · EU 2022-502437-25-00